Search Results - Johan Linderoth

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    P106: Dose intensive brentuximab vedotin for platinum resistant recurrent Hodgkin lymphoma is a feasible treatment option - a single center experience by Axel Erenmalm, Johan Linderoth

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  2. 2

    P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma. by Johan Linderoth, Eva Freyhult, Ellinor Andreasson, Ann-Sofie Johansson, Anne Andersson, Ingrid Glimelius, Gunilla Enblad, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  3. 3

    Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years by Björn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Ingemar Lagerlöf, Ann‐Sofie Johansson, Marzia Palma, Lotta Hansson, Johan Linderoth, Christina Goldkuhl, Daniel Molin

    Published in eJHaem (2021-08-01)
    Get full text
    Article


  4. 4

    T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients by Ninja Övergaard, Kjersti Lia, Peter Asdahl, Per Wikman, Ingrid Glimelius, Ingemar Lagerlöf., Ann-Sofie Johansson, Lotta Hansson, Gunilla Enblad, Johan Linderoth, Christina Goldkuhl, Alexander Fosså, Peter Kamper, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  5. 5

    Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the pros... by Alexander Fosså, Daniel Molin, Paul J. Bröckelmann, Gundolf Schneider, Ulf Schnetzke, Johan Linderoth, Peter M. H. Kamper, Sirpa M. Leppä, Julia Meissner, Valdete Schaub, Kjersti Lia, Michael Fuchs, Peter Borchmann, Boris Böll

    Published in HemaSphere (2025-03-01)
    Get full text
    Article


  6. 6

    P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients by Christina Goldkuhl, Alexandru Dasu, Anna Bäck, Gunilla Enblad, Ingrid Glimelius, Annika Hall, Lotta Hansson, Urban Jerlström., Ann-Sofie Johansson, Jenny Kahlmeter-Brandell, Johan Linderoth, Marzia Palma, Hillevi Rylander, Marika Enmark, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  7. 7

    The dual role of CD70 in B‐cell lymphomagenesis by Man Nie, Weicheng Ren, Xiaofei Ye, Mattias Berglund, Xianhuo Wang, Karin Fjordén, Likun Du, Yvonne Giannoula, Dexin Lei, Wenjia Su, Wei Li, Dongbing Liu, Johan Linderoth, Chengyi Jiang, Huijing Bao, Wenqi Jiang, Huiqiang Huang, Yong Hou, Shida Zhu, Gunilla Enblad, Mats Jerkeman, Kui Wu, Huilai Zhang, Rose‐Marie Amini, Zhi‐Ming Li, Qiang Pan‐Hammarström

    Published in Clinical and Translational Medicine (2022-12-01)
    Get full text
    Article


Search Tools: